A Short-Term Cost-of-Treatment Model for Type 2 Diabetes: Comparison of Glipizide Gastrointestinal Therapeutic System, Metformin, and Acarbose

August 1, 1999
Joe W. Ramsdell, MD

,
Joseph A. Grossman, MD

,
Jennifer M. Stevens, PharmD

,
Marc F. Botteman, MSc, MA

,
Raul Arocho, PhD

Volume 5, Issue 8